 MELBOURNE, Australia, Sept. 08, 2022 GLOBE NEWSWIRE -- Incannex Healthcare Limited Nasdaq: IXHL ASX: IHL, Incannex or the Company a pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference. 